PULSAR Combined With Immunotherapy and Chemotherapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (shu pei) · peishu1991@sina.com · +86 028 85422654

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

Advanced Cholangiocarcinoma · FGFR2 Fusions · Gene Rearrangement

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States · Tampa, United States

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Alamitos, United States · Los Angeles, United States

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Cholangiocarcinoma · Hilar Cholangiocarcinoma · Bile Duct Cancer

Abroad (travel likely)RecruitingPHASE2

Jinan, China

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Bile Duct Cancer · Cholangiocarcinoma · Cholangiocarcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Boston, United States